Relx Plc (NYSE:RELX – Get Free Report) saw a significant growth in short interest in February. As of February 28th, there was short interest totalling 2,390,000 shares, a growth of 22.6% from the February 13th total of 1,950,000 shares. Based on an average daily trading volume, of 637,000 shares, the short-interest ratio is currently 3.8 days. Currently, 0.1% of the shares of the company are short sold.
Relx Price Performance
Shares of NYSE RELX traded down $0.63 during trading on Tuesday, hitting $48.97. The company had a trading volume of 485,902 shares, compared to its average volume of 730,686. The stock has a fifty day simple moving average of $48.94 and a two-hundred day simple moving average of $47.62. Relx has a fifty-two week low of $40.25 and a fifty-two week high of $51.99. The firm has a market capitalization of $90.88 billion, a price-to-earnings ratio of 26.33, a price-to-earnings-growth ratio of 2.73 and a beta of 0.90. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46.
Relx Increases Dividend
The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be given a dividend of $0.5586 per share. The ex-dividend date is Friday, May 9th. This is a positive change from Relx’s previous semi-annual dividend of $0.23. This represents a yield of 1.6%. Relx’s payout ratio is presently 59.68%.
Hedge Funds Weigh In On Relx
Analyst Ratings Changes
A number of research firms have weighed in on RELX. StockNews.com cut shares of Relx from a “buy” rating to a “hold” rating in a report on Tuesday, March 4th. Redburn Atlantic began coverage on shares of Relx in a report on Wednesday, January 8th. They issued a “buy” rating for the company. Finally, Barclays raised shares of Relx from an “equal weight” rating to an “overweight” rating in a report on Friday.
Read Our Latest Stock Report on RELX
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Stories
- Five stocks we like better than Relx
- Breakout Stocks: What They Are and How to Identify Them
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Must-Own Stocks to Build Wealth This Decade
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.